vs

Side-by-side financial comparison of Cushman & Wakefield Ltd. (CWK) and TE Connectivity (TEL). Click either name above to swap in a different company.

TE Connectivity is the larger business by last-quarter revenue ($4.7B vs $2.9B, roughly 1.6× Cushman & Wakefield Ltd.). TE Connectivity runs the higher net margin — 16.1% vs -0.8%, a 16.8% gap on every dollar of revenue. On growth, TE Connectivity posted the faster year-over-year revenue change (21.7% vs 10.8%). TE Connectivity produced more free cash flow last quarter ($607.0M vs $234.3M). Over the past eight quarters, Cushman & Wakefield Ltd.'s revenue compounded faster (15.5% CAGR vs 8.5%).

Cushman & Wakefield Inc. is an American global commercial real estate and property management services firm. The company's corporate headquarters is located in Chicago, Illinois. It is named after co-founders J. Clydesdale Cushman and Bernard Wakefield.

TE Connectivity plc is an American-Irish domiciled technology company that designs and manufactures electrical and electronic components. It serves several industries, including automotive, aerospace, defense, medical, and energy.

CWK vs TEL — Head-to-Head

Bigger by revenue
TEL
TEL
1.6× larger
TEL
$4.7B
$2.9B
CWK
Growing faster (revenue YoY)
TEL
TEL
+10.9% gap
TEL
21.7%
10.8%
CWK
Higher net margin
TEL
TEL
16.8% more per $
TEL
16.1%
-0.8%
CWK
More free cash flow
TEL
TEL
$372.7M more FCF
TEL
$607.0M
$234.3M
CWK
Faster 2-yr revenue CAGR
CWK
CWK
Annualised
CWK
15.5%
8.5%
TEL

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CWK
CWK
TEL
TEL
Revenue
$2.9B
$4.7B
Net Profit
$-22.4M
$750.0M
Gross Margin
37.2%
Operating Margin
6.1%
20.6%
Net Margin
-0.8%
16.1%
Revenue YoY
10.8%
21.7%
Net Profit YoY
-119.8%
42.0%
EPS (diluted)
$-0.10
$2.53

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CWK
CWK
TEL
TEL
Q4 25
$2.9B
$4.7B
Q3 25
$2.6B
$4.7B
Q2 25
$2.5B
$4.5B
Q1 25
$2.3B
$4.1B
Q4 24
$2.6B
$3.8B
Q3 24
$2.3B
$4.1B
Q2 24
$2.3B
$4.0B
Q1 24
$2.2B
$4.0B
Net Profit
CWK
CWK
TEL
TEL
Q4 25
$-22.4M
$750.0M
Q3 25
$51.4M
$663.0M
Q2 25
$57.3M
$638.0M
Q1 25
$1.9M
$13.0M
Q4 24
$112.9M
$528.0M
Q3 24
$33.7M
$276.0M
Q2 24
$13.5M
$573.0M
Q1 24
$-28.8M
$541.0M
Gross Margin
CWK
CWK
TEL
TEL
Q4 25
37.2%
Q3 25
35.0%
Q2 25
35.3%
Q1 25
35.2%
Q4 24
35.5%
Q3 24
34.0%
Q2 24
34.8%
Q1 24
34.4%
Operating Margin
CWK
CWK
TEL
TEL
Q4 25
6.1%
20.6%
Q3 25
4.1%
19.3%
Q2 25
4.9%
18.9%
Q1 25
2.0%
18.1%
Q4 24
6.6%
18.0%
Q3 24
3.2%
16.0%
Q2 24
3.1%
19.0%
Q1 24
0.9%
17.4%
Net Margin
CWK
CWK
TEL
TEL
Q4 25
-0.8%
16.1%
Q3 25
2.0%
14.0%
Q2 25
2.3%
14.1%
Q1 25
0.1%
0.3%
Q4 24
4.3%
13.8%
Q3 24
1.4%
6.8%
Q2 24
0.6%
14.4%
Q1 24
-1.3%
13.6%
EPS (diluted)
CWK
CWK
TEL
TEL
Q4 25
$-0.10
$2.53
Q3 25
$0.22
$2.23
Q2 25
$0.25
$2.14
Q1 25
$0.01
$0.04
Q4 24
$0.49
$1.75
Q3 24
$0.14
$0.96
Q2 24
$0.06
$1.86
Q1 24
$-0.13
$1.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CWK
CWK
TEL
TEL
Cash + ST InvestmentsLiquidity on hand
$784.2M
$1.3B
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$2.0B
$13.0B
Total Assets
$7.7B
$25.6B
Debt / EquityLower = less leverage
1.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CWK
CWK
TEL
TEL
Q4 25
$784.2M
$1.3B
Q3 25
$634.4M
$1.3B
Q2 25
$618.2M
$672.0M
Q1 25
$623.2M
$2.6B
Q4 24
$793.3M
$1.3B
Q3 24
$775.4M
$1.3B
Q2 24
$567.3M
$1.5B
Q1 24
$553.5M
$1.2B
Total Debt
CWK
CWK
TEL
TEL
Q4 25
$2.7B
Q3 25
$2.8B
Q2 25
$3.0B
Q1 25
$3.0B
Q4 24
$3.0B
Q3 24
$3.1B
Q2 24
$3.1B
Q1 24
$3.2B
Stockholders' Equity
CWK
CWK
TEL
TEL
Q4 25
$2.0B
$13.0B
Q3 25
$2.0B
$12.6B
Q2 25
$1.9B
$12.4B
Q1 25
$1.8B
$12.1B
Q4 24
$1.8B
$12.4B
Q3 24
$1.7B
$12.4B
Q2 24
$1.6B
$12.6B
Q1 24
$1.6B
$12.4B
Total Assets
CWK
CWK
TEL
TEL
Q4 25
$7.7B
$25.6B
Q3 25
$7.7B
$25.1B
Q2 25
$7.6B
$24.9B
Q1 25
$7.4B
$23.7B
Q4 24
$7.5B
$22.4B
Q3 24
$7.5B
$22.9B
Q2 24
$7.3B
$22.9B
Q1 24
$7.5B
$22.8B
Debt / Equity
CWK
CWK
TEL
TEL
Q4 25
1.40×
Q3 25
1.45×
Q2 25
1.57×
Q1 25
1.70×
Q4 24
1.73×
Q3 24
1.81×
Q2 24
1.91×
Q1 24
1.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CWK
CWK
TEL
TEL
Operating Cash FlowLast quarter
$257.3M
$865.0M
Free Cash FlowOCF − Capex
$234.3M
$607.0M
FCF MarginFCF / Revenue
8.0%
13.0%
Capex IntensityCapex / Revenue
0.8%
5.5%
Cash ConversionOCF / Net Profit
1.15×
TTM Free Cash FlowTrailing 4 quarters
$293.0M
$3.1B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CWK
CWK
TEL
TEL
Q4 25
$257.3M
$865.0M
Q3 25
$235.5M
$1.4B
Q2 25
$9.6M
$1.2B
Q1 25
$-162.0M
$653.0M
Q4 24
$115.2M
$878.0M
Q3 24
$196.1M
$1.0B
Q2 24
$21.8M
$1.0B
Q1 24
$-125.1M
$710.0M
Free Cash Flow
CWK
CWK
TEL
TEL
Q4 25
$234.3M
$607.0M
Q3 25
$225.0M
$1.1B
Q2 25
$300.0K
$957.0M
Q1 25
$-166.6M
$423.0M
Q4 24
$105.9M
$673.0M
Q3 24
$186.7M
$829.0M
Q2 24
$10.0M
$857.0M
Q1 24
$-135.6M
$543.0M
FCF Margin
CWK
CWK
TEL
TEL
Q4 25
8.0%
13.0%
Q3 25
8.6%
24.2%
Q2 25
0.0%
21.1%
Q1 25
-7.3%
10.2%
Q4 24
4.0%
17.5%
Q3 24
8.0%
20.4%
Q2 24
0.4%
21.5%
Q1 24
-6.2%
13.7%
Capex Intensity
CWK
CWK
TEL
TEL
Q4 25
0.8%
5.5%
Q3 25
0.4%
5.7%
Q2 25
0.4%
5.1%
Q1 25
0.2%
5.6%
Q4 24
0.4%
5.3%
Q3 24
0.4%
5.2%
Q2 24
0.5%
3.7%
Q1 24
0.5%
4.2%
Cash Conversion
CWK
CWK
TEL
TEL
Q4 25
1.15×
Q3 25
4.58×
2.14×
Q2 25
0.17×
1.86×
Q1 25
-85.26×
50.23×
Q4 24
1.02×
1.66×
Q3 24
5.82×
3.78×
Q2 24
1.61×
1.76×
Q1 24
1.31×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CWK
CWK

Equity Method Investment Nonconsolidated Investee Or Group Of Investees$1.8B61%
Other$1.1B39%

TEL
TEL

Automotive Industry End Market$1.9B40%
Digital Data Networks$707.0M15%
Automation And Connected Living Industry End Market$549.0M12%
Energy Industry End Market$406.0M9%
Aerospace Defense And Marine Industry End Market$381.0M8%
Commercial Transportation Industry End Market$370.0M8%
Sensors Industry End Market$212.0M5%
Medical Industry End Market$159.0M3%

Related Comparisons